Strategies of neutralization of the direct oral anticoagulants effect: review of the literature. (Record no. 29203632)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01305 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518014519.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201906s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1950-6112 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1684/abc.2018.1400 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Jourdi, Georges |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20190624 |
245 00 - TITLE STATEMENT | |
Title | Strategies of neutralization of the direct oral anticoagulants effect: review of the literature. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Annales de biologie clinique |
Date of publication, distribution, etc. | 02 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 67-78 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anticoagulants |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antidotes |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antithrombins |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dabigatran |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Factor Xa |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Factor Xa Inhibitors |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hemorrhage |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recombinant Proteins |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rivaroxaban |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Le Bonniec, Bernard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gouin-Thibault, Isabelle |
773 0# - HOST ITEM ENTRY | |
Title | Annales de biologie clinique |
Related parts | vol. 77 |
-- | no. 1 |
-- | p. 67-78 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1684/abc.2018.1400">https://doi.org/10.1684/abc.2018.1400</a> |
Public note | Available from publisher's website |
No items available.